Biblio

Found 21 results
Filters: Keyword is Orexins  [Clear All Filters]
2015
Shan L, Dauvilliers Y, Siegel JM.  2015.  Interactions of the histamine and hypocretin systems in CNS disorders.. Nature Reviews Neurology. 11(7):401-13.
Dell L-A, Spocter MA, Patzke N, Karlson KÆ, Alagaili AN, Bennett NC, Muhammed OB, Bertelsen MF, Siegel JM, Manger PR.  2015.  Orexinergic bouton density is lower in the cerebral cortex of cetaceans compared to artiodactyls.. J Chem Neuroanat. 68:61-76.
2013
Blouin AM, Fried I, Wilson CL, Staba RJ, Behnke EJ, Lam HA, Maidment NT, Karlsson KÆ, Lapierre JL, Siegel JM.  2013.  Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction.. Nature Communications. 4:1547.
Blouin AM, Siegel JM.  2013.  Relation of melanin concentrating hormone levels to sleep, emotion and hypocretin levels.. Sleep. 36(12):1777.
2012
Dell L-A, Patzke N, Bhagwandin A, Bux F, Fuxe K, Barber G, Siegel JM, Manger PR.  2012.  Organization and number of orexinergic neurons in the hypothalamus of two species of Cetartiodactyla: a comparison of giraffe (Giraffa camelopardalis) and harbour porpoise (Phocoena phocoena).. J Chem Neuroanat. 44(2):98-109.
2011
McGregor R, Wu M-F, Barber G, Ramanathan L, Siegel JM.  2011.  Highly specific role of hypocretin (orexin) neurons: differential activation as a function of diurnal phase, operant reinforcement versus operant avoidance and light level.. J Neurosci. 31(43):15455-67.
Siegel JM.  2011.  REM sleep: a biological and psychological paradox.. Sleep Med Rev. 15(3):139-42.
Wu M-F, Nienhuis R, Maidment N, Lam HA, Siegel JM.  2011.  Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy.. J Neurosci. 31(17):6305-10.
2009
Scammell TE, Willie JT, Guilleminault C, Siegel JM.  2009.  A consensus definition of cataplexy in mouse models of narcolepsy.. Sleep. 32(1):111-6.
Thannickal TC, Nienhuis R, Siegel JM.  2009.  Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.. Sleep. 32(8):993-8.
2008
Thannickal TC, Lai Y-Y, Siegel JM.  2008.  Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease.. Brain. 131(Pt 1):e87.
2007
Thannickal TC, Lai Y-Y, Siegel JM.  2007.  Hypocretin (orexin) cell loss in Parkinson's disease.. Brain. 130(Pt 6):1586-95.
Deadwyler SA, Porrino L, Siegel JM, Hampson RE.  2007.  Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates.. J Neurosci. 27(52):14239-47.
2005
Mileykovskiy BY, Kiyashchenko LI, Siegel JM.  2005.  Behavioral correlates of activity in identified hypocretin/orexin neurons.. Neuron. 46(5):787-98.
Blouin AM, Thannickal TC, Worley PF, Baraban JM, Reti IM, Siegel JM.  2005.  Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.. Neurology. 65(8):1189-92.
2004
Siegel JM.  2004.  Hypocretin (orexin): role in normal behavior and neuropathology.. Annual Reviews of Psychology. 55:125-48.
2003
Thannickal TC, Siegel JM, Nienhuis R, Moore RY.  2003.  Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy.. Brain Pathology. 13(3):340-51.
2000
Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM.  2000.  Reduced number of hypocretin neurons in human narcolepsy.. Neuron. 27(3):469-74.
John J, Wu MF, Siegel JM.  2000.  Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs.. Sleep Res Online. 3(1):23-8.